GenoSpace Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 41

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

GenoSpace General Information

Description

Developer of precision medicine platform designed to harness molecular data. The company's platform makes biomedical data accessible for those on the front lines of care delivery for clinical-genomic data aggregation, trial matching and recruiting as well as clinical decision support, thereby improving individual patient outcomes and accelerating drug development and research.

Contact Information

Website
www.genospace.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 700 Massachusetts Avenue
  • Cambridge, MA 02139
  • United States
+1 (617) 000-0000
Primary Industry
Decision/Risk Analysis
Parent Company
McKesson
Vertical(s)
SaaS, TMT
Corporate Office
  • 700 Massachusetts Avenue
  • Cambridge, MA 02139
  • United States
+1 (617) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GenoSpace Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GenoSpace‘s full profile, request access.

Request a free trial

GenoSpace Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of precision medicine platform designed to harness molecular data. The company's platform makes biomedical dat
Decision/Risk Analysis
Cambridge, MA
41 As of 2024
000
000000&0

000000

iqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
0000000000000 000000
Philadelphia, PA
000 As of 0000
000.00
00000 0000-00-00
00000000000 000.00

000000

liqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi u
0000000000000 000000
Morrisville, NC
000 As of 0000
00000
000000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GenoSpace Competitors (47)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Proscia Private Equity-Backed Philadelphia, PA 000 000.00 00000000000 000.00
NantHealth Formerly VC-backed Morrisville, NC 000 00000 000000000000 00000
PierianDx Private Equity-Backed Creve Coeur, MO 000 000.00 000000000000 000.00
Genalice Formerly PE-Backed Harderwijk, Netherlands 00 000000 - 000
Congenica Venture Capital-Backed Cambridge, United Kingdom 00 000.00 0000000000 000.00
You’re viewing 5 of 47 competitors. Get the full list »

GenoSpace Patents

  • 8

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 8

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

GenoSpace Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190287680-A1 Techniques for integrating proxy nodes into graph-model-based investigatory-event mappings Active 13-Mar-2018 000000000000
US-10566093-B2 Data integration using graph structures Active 13-Mar-2018 000000000000 00
US-10558709-B2 Techniques for generating investigatory-event mappings using graph-structure trajectories Active 13-Mar-2018 000000000000 00
US-20220277848-A1 Techniques for integrating proxy nodes into graph-model-based investigatory-event mappings Active 13-Mar-2018 000000000000 00
US-11250953-B2 Techniques for integrating proxy nodes into graph-model-based investigatory-event mappings Active 13-Mar-2018 G06F16/90335 00
To view GenoSpace’s complete patent history, request access »

GenoSpace Executive Team (6)

Name Title Board Seat
Mick Correll Co-Founder & President
You’re viewing 1 of 6 executive team members. Get the full list »

GenoSpace Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GenoSpace Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GenoSpace‘s full profile, request access.

Request a free trial

GenoSpace FAQs

  • When was GenoSpace founded?

    GenoSpace was founded in 2011.

  • Who is the founder of GenoSpace?

    Mick Correll is the founder of GenoSpace.

  • Where is GenoSpace headquartered?

    GenoSpace is headquartered in Cambridge, MA.

  • What is the size of GenoSpace?

    GenoSpace has 41 total employees.

  • What industry is GenoSpace in?

    GenoSpace’s primary industry is Decision/Risk Analysis.

  • Is GenoSpace a private or public company?

    GenoSpace is a Private company.

  • What is GenoSpace’s current revenue?

    The current revenue for GenoSpace is 00000.

  • How much funding has GenoSpace raised over time?

    GenoSpace has raised $5M.

  • Who are GenoSpace’s investors?

    Sarah Cannon Research Institute and Thomson Reuters have invested in GenoSpace.

  • Who are GenoSpace’s competitors?

    Proscia, NantHealth, PierianDx, Genalice, and Congenica are some of the 47 competitors of GenoSpace.

  • When was GenoSpace acquired?

    GenoSpace was acquired on 31-Oct-2022.

  • Who acquired GenoSpace?

    GenoSpace was acquired by McKesson.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »